Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice
NCT Number: NCT06475222
Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Phases: NA
Conditions: Rice Serum|Rice Mask|Rice Jelly
Interventions: OTHER: Study 1: Facial serum with alpha albutin|OTHER: Study 1: Facial serum with Tubtim Chumpae rice extract|OTHER: Study 2: Facial mask with Hom Pathum rice extract|OTHER: Study 3: Control jelly|OTHER: Study 3: Jelly with Tubtim Chumpae rice|OTHER: Study 3: Jelly with Hom Pathum rice
Sponsor: Burapha University
Sex: ALL
Age: ADULT
Enrollment: 115
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2024-09-01
Completion Date: 2024-12-31
Locations: Piyapong Prasertsri, Mueang, ChonBuri, 20131, Thailand

Summary:
This study consisted of three sub-studies including 1) development and evaluation of facial serum from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants 2) development and evaluation of facial mask from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants and 3) development and evaluation of ready-to-drink jelly from Thai rice on controlling blood glucose and endurance time in healthy participants.

Primary Outcome Measures: Level of skin moisture, Studies 1 and 2 determine level of skin moisture in arbitrary unit (no unit) using Multiprobe Adapter System with Corneometer® CM 825 probe., Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]|Level of skin elasticity, Studies 1 and 2 determine level of skin elasticity in arbitrary unit (no unit) using Multiprobe Adapter System with Cutometer® 580 probe., Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]|Level of skin oiliness, Studies 1 and 2 determine level of skin oiliness in arbitrary unit (no unit) using Multiprobe Adapter System with Sebumeter® SM 815 probe., Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]|Level of skin melanin, Studies 1 and 2 determine level of skin melanin in arbitrary unit (no unit) using Multiprobe Adapter System with Mexameter® MX18 probe., Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]|Level of blood glucose, Study 3.1 determines level of blood glucose in mg/dL unit, Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes|Level of maximal oxygen consumption, Study 3.2 determines level of maximal oxygen consumption in mL/kg/min unit by walking or running on treadmill at intensity of 80% maximal heart rate., After jelly consumption for 30 minutes|Concentration of interferon-gamma, Study 3.2 determines concentration of interferon-gamma in serum in pg (picogram)/mL unit, Before and immediately after maximal oxygen consumption test|Concentration of tumor necrosis factor-alpha, Study 3.2 determines concentration of tumor necrosis factor-alpha in serum in pg (picogram)/mL unit, Before and immediately after maximal oxygen consumption test|Concentration of interleukin-10, Study 3.2 determines concentration of interleukin-10 in serum in pg (picogram)/mL unit, Before and immediately after maximal oxygen consumption test|Level of superoxide dismutase activity, Study 3.2 determines level of superoxide dismutase activity in percentage (%) unit, Before and immediately after maximal oxygen consumption test|Concentration of malondialdehyde, Study 3.2 determines concentration of malondialdehyde in micromolar (uM) unit, Before and immediately after maximal oxygen consumption test